OBJECTIVE: To examine providers' HPV vaccine communication among adult cigarette smokers with household members aged ≤26 years. METHODS: In this cross-sectional study, we used 2017 Health Information National Trends Survey (HINTS 5, Cycle 1; N = 3191) data to derive a subsample (n = 725/3191; 22.7%) of adults with household members aged ≤26 years. Forward stepwise multivariable logistic regression analyses were performed to examine providers' HPV vaccine communication, adjusting for patients' smoking status (main independent variable); HPV awareness and knowledge; HPV vaccine awareness and beliefs; and sociodemographic characteristics that contribute to disparities in HPV vaccine coverage. RESULTS: Current/former smokers (35.0%) had lower HPV-related awareness/knowledge than nonsmokers (65%). Few reported providers discussed (27.4%) or recommended (24.0%) HPV vaccine. Non-Hispanic Whites who knew HPV was a sexually transmitted disease and heard of HPV vaccine were 2-6 times more likely to report provider HPV vaccine communication. Provider HPV vaccine communication differences by smoking status were not statistically significant. CONCLUSION: Providers' HPV vaccine communication was higher among adults who had higher HPV-related awareness/knowledge. Although active/passive exposure to cigarette smoke increases cervical cancer risk, providers' HPV vaccine communication was not increased for current/former smokers. PRACTICE IMPLICATIONS: Current/former smokers' HPV-related awareness/knowledge and providers' HPV vaccine communication need to be increased.
OBJECTIVE: To examine providers' HPV vaccine communication among adult cigarette smokers with household members aged ≤26 years. METHODS: In this cross-sectional study, we used 2017 Health Information National Trends Survey (HINTS 5, Cycle 1; N = 3191) data to derive a subsample (n = 725/3191; 22.7%) of adults with household members aged ≤26 years. Forward stepwise multivariable logistic regression analyses were performed to examine providers' HPV vaccine communication, adjusting for patients' smoking status (main independent variable); HPV awareness and knowledge; HPV vaccine awareness and beliefs; and sociodemographic characteristics that contribute to disparities in HPV vaccine coverage. RESULTS: Current/former smokers (35.0%) had lower HPV-related awareness/knowledge than nonsmokers (65%). Few reported providers discussed (27.4%) or recommended (24.0%) HPV vaccine. Non-Hispanic Whites who knew HPV was a sexually transmitted disease and heard of HPV vaccine were 2-6 times more likely to report provider HPV vaccine communication. Provider HPV vaccine communication differences by smoking status were not statistically significant. CONCLUSION: Providers' HPV vaccine communication was higher among adults who had higher HPV-related awareness/knowledge. Although active/passive exposure to cigarette smoke increases cervical cancer risk, providers' HPV vaccine communication was not increased for current/former smokers. PRACTICE IMPLICATIONS: Current/former smokers' HPV-related awareness/knowledge and providers' HPV vaccine communication need to be increased.
Authors: Susan T Vadaparampil; Teri L Malo; Jessica A Kahn; Daniel A Salmon; Ji-Hyun Lee; Gwendolyn P Quinn; Richard G Roetzheim; Karen L Bruder; Tina M Proveaux; Xiuhua Zhao; Neal A Halsey; Anna R Giuliano Journal: Am J Prev Med Date: 2014-01 Impact factor: 5.043
Authors: K L Wallin; F Wiklund; T Angström; F Bergman; U Stendahl; G Wadell; G Hallmans; J Dillner Journal: N Engl J Med Date: 1999-11-25 Impact factor: 91.245
Authors: G E Matt; P J E Quintana; M F Hovell; J T Bernert; S Song; N Novianti; T Juarez; J Floro; C Gehrman; M Garcia; S Larson Journal: Tob Control Date: 2004-03 Impact factor: 7.552
Authors: Emiko Petrosky; Joseph A Bocchini; Susan Hariri; Harrell Chesson; C Robinette Curtis; Mona Saraiya; Elizabeth R Unger; Lauri E Markowitz Journal: MMWR Morb Mortal Wkly Rep Date: 2015-03-27 Impact factor: 17.586
Authors: E Sigstad; A K Lie; T Luostarinen; J Dillner; E Jellum; M Lehtinen; S Thoresen; V Abeler Journal: Br J Cancer Date: 2002-07-15 Impact factor: 7.640